Agilent Technologies Inc (A): Today's Featured Health Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Agilent Technologies ( A) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.7%. By the end of trading, Agilent Technologies rose $0.52 (1.1%) to $47.95 on light volume. Throughout the day, 1,648,827 shares of Agilent Technologies exchanged hands as compared to its average daily volume of 2,594,300 shares. The stock ranged in a price between $47.29-$48.05 after having opened the day at $47.49 as compared to the previous trading day's close of $47.43. Other companies within the Health Services industry that increased today were: AxoGen ( AXGN), up 12.9%, Rosetta Genomics ( ROSG), up 8.5%, IsoRay ( ISR), up 7.4% and Escalon Medical Corporation ( ESMC), up 6.4%.

Agilent Technologies is on the leading edge of nearly every major trend in communications and life sciences. From optical and wireless communications to disease and discovery research, Agilent delivers product and technology innovations that benefit millions of people around the world. Agilent Technologies has a market cap of $16.4 billion and is part of the health care sector. Shares are up 15.9% year to date as of the close of trading on Friday. Currently there are 13 analysts that rate Agilent Technologies a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Agilent Technologies as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, reasonable valuation levels, expanding profit margins, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, Allied Healthcare Products ( AHPI), down 8.4%, Diversicare Healthcare Services ( DVCR), down 7.9%, Advocat ( AVCA), down 7.9% and Span-America Medical ( SPAN), down 6.3% , were all laggards within the health services industry with Express Scripts ( ESRX) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

What a Difference a Day Makes for New SEC Rule

Jim Cramer: Agilent Technology Has Been One of My Favorites

Jim Cramer -- Agilent Is 'Continuing to Defy Gravity'

Biotech Movers: Disappointment for Bristol-Myers Kidney Combo Boosts Exelixis